"T1: low to heterogeneous signal intensity 1,6"
"T2: heterogeneous to high signal intensity 1,6"
"T1 C+ (Gd): can show early heterogeneous and slowly progressive enhancement 11"
"It was first described by renowned American surgical pathologist, Virginia K Frantz (1896-1967) 9 et al. in 1959, hence the historical name "Frantz tumour" 4,5."
"Hamoudi tumour"
"Gruber-Frantz tumour (or just Frantz tumour)"
"The tumours frequently contain varying amounts of necrosis, haemorrhage, and cystic change. Lesions can be large at the time of diagnosis (median size ~8 cm) 2,14. Elevated β-HCG has been reported 15."
Expected headings
"Associations"
"There is a greater predilection to occur at the pancreatic tail."
"Typical SPTs larger than 3 cm, and well-defined with central cystic and peripheral solid components. Enhancement was heterogeneous due to haemorrhagic degeneration; large atypical SPTs were partly calcified solid masses or cystic masses 7."